EX-10.5



 Exhibit 10.5 

VIKING THERAPEUTICS, INC. 

2014 EQUITY INCENTIVE PLAN 
  

 
 Stock
Appreciation Rights Award Agreement 
  
  

Unless otherwise defined herein, the terms defined in the Viking Therapeutics, Inc. 2014 Equity Incentive Plan (as amended or restated from
time to time, the “Plan”) will have the same defined meanings in this Stock Appreciation Rights Award Agreement (this “Award Agreement”), which includes the Notice of Stock Appreciation Rights Grant
(the “Notice of Grant”) and the Terms and Conditions of Stock Appreciation Rights Grant attached hereto as EXHIBIT A. 

NOTICE OF STOCK APPRECIATION RIGHTS GRANT 

Participant has been granted the right to receive an award of Stock Appreciation Rights (“SARs”), subject to the terms
and conditions of the Plan and this Award Agreement, as follows: 
  

			
	  
 Name of
Participant
  
	  	 
	  

Grant Number
  
	  	 
	  

Grant Date
  
	  	  

            , 20    

 

	  

Vesting

Commencement Date        
  
	  	  

                 , 20    

 

	  

Exercise price per
 Share

 
	  	  

$         
  

	  

Total Number of Shares
 Granted

 
	  	 
	  

Vesting
	  	  

[The Shares subject to the SARs will vest with respect to 1/4 (25%) of the total number of Shares designated above on the date that is one (1) year after the
Vesting Commencement Date, and the balance of the Shares will vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date on each one (1)-month date thereafter,
subject to Participant’s Continuous Service through each such date, inclusive.]
  

	  

Expiration Date
	  	  

                 , 20    1
 Subject to the terms of any employment agreement, offer letter, consulting agreement or similar agreement
between Participant, on the one hand, and the Company or any of its Affiliates, on the other hand, that is in effect when
  


  

	1 	Ten years from the Grant Date. 


  
 1 









			
	 	  	  

Participant’s Continuous Service terminates, the SARs shall expire, be canceled and automatically become null and void immediately upon the termination of
Participant’s Continuous Service for any reason, but only to the extent Participant’s rights under the SARs have not become vested on or before the date Participant’s Continuous Service ends, except to the extent set forth in the Plan
with respect to Participant’s death or disability.
  

	  

Recapture
	  	  

 ̈     Section 14(a) of the Plan shall apply
regarding Termination, Rescission and Recapture of the

           SARs or the Shares subject to the SARs.

 


 By Participant’s signature and the signature of the representative of Viking Therapeutics, Inc. (the
“Company”) below, Participant and the Company agree that this award of SARs is granted under, and governed by the terms and conditions of, the Plan and this Award Agreement, including the Terms and Conditions of Stock
Appreciation Rights Grant (including any country-specific addendum thereto) attached hereto as EXHIBIT A, all of which are made a part of this document. Participant has reviewed the Plan and this Award Agreement in their
entirety, has had an opportunity to obtain the advice of counsel, accountants and advisors prior to executing this Award Agreement and fully understands all provisions of the Plan and this Award Agreement. Participant hereby agrees to accept as
binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan and this Award Agreement. Participant further agrees to notify the Company upon any change in the residence address indicated
below. 
 Participant acknowledges that the Plan and the prospectus describing the Plan (the “Prospectus”) are
available on the Company’s intranet under “            ” at “            ”; provided that a paper
copy of the Plan and the Prospectus are available upon request by contacting the [Human Resources Department] at             
(            )              -             . By signing below,
Participant acknowledges receipt of the Plan and the Prospectus. 
  

							
	PARTICIPANT:	 		 	VIKING THERAPEUTICS, INC.
			
	  
	 		 	  

	Signature	 		 	By
			
	  
	 		 	  

	Print Name	 		 	Name
			
	Residence Address:	 		 	  

	  
	 		 	Title
			
	  
	 		 	
			
	  
	 		 	


  
 2 








 EXHIBIT A 

TERMS AND CONDITIONS OF STOCK APPRECIATION
RIGHTS GRANT 
  

	1.	Grant. The Company hereby grants to Participant under the Plan SARs with respect to the number of Shares set forth in the Notice of Grant at the exercise price per Share set forth in the Notice of Grant (the
“Exercise Price”), subject to all of the terms and conditions in this Award Agreement and the Plan, which is incorporated herein by reference. Subject to Section 19 of the Plan, in the event of a conflict between the
terms and conditions of the Plan and the terms and conditions of this Award Agreement, the terms and conditions of the Plan will prevail in all respects. 

  

	2.	Vesting Schedule. Except as provided in Section 3, and subject to Section 7, the SARs awarded by this Award Agreement will vest in accordance with the vesting provisions set forth in the Notice of
Grant. No [cash will be paid]2 [Shares will be issued and no cash will be paid]3 to Participant before the SARs vest and are exercised. Shares
scheduled to vest on a certain date, or upon the occurrence of a certain condition, will not vest in Participant in accordance with any of the provisions of this Award Agreement unless Participant will have been in Continuous Service from the Grant
Date until the date such vesting occurs. Notwithstanding the foregoing, the Committee shall have the sole and absolute discretion to determine when Participant is no longer providing Continuous Service for purposes of participation in the Plan and
this award of SARs if other than a last day of employment or services. The termination of vesting will apply regardless of whether Participant is entitled to a period of notice of termination which would otherwise permit a greater portion of the
SARs to vest. For greater certainty, the date on which Participant ceases to have been in Continuous Service shall be based upon the last day of actual Continuous Service to the Company or its Affiliate (and specifically does not include any period
of notice that the Company or its Affiliate may be required to provide to Participant). 

  

	3.	Committee Discretion. The Committee, in its sole and absolute discretion, may accelerate the vesting of the balance, or some lesser portion of the balance, of the unvested SARs at any time, subject to the terms
of the Plan. If so accelerated, the SARs will be considered as having vested as of the date specified by the Committee. 


Notwithstanding anything in the Plan or this Award Agreement to the contrary, if the vesting of the balance, or some lesser portion of the
balance, of the SARs is accelerated in connection with Participant’s termination of Continuous Service (provided that such termination is a “separation from service” within the meaning of Code Section 409A, as determined by the
Company or the Committee), other than due to death, and if (x) Participant is a “specified employee,” within the meaning of Code Section 409A, at the time of such termination of Continuous Service, and (y) the payment of
such accelerated SARs will result in the imposition of additional tax under Code Section 409A, if paid to Participant on or within the six (6)-month period following Participant’s termination of 

 
  

	2 	Include if SARs may be settled only in cash. 


	3 	 Include if SARs may be settled (i) only in Shares or (ii) in cash or Shares.




  
 A-1 








 
Continuous Service, then the payment of such accelerated SARs will not be made until the date six (6) months and one (1) day following the date of termination of Participant’s
Continuous Service, unless Participant dies following Participant’s termination of Continuous Service, in which case, the SARs will be paid in [cash]4 [Shares]5 [cash or Shares]6 to Participant’s estate as soon as practicable following Participant’s death. It is the intent of this Award Agreement
to comply with the requirements of Code Section 409A, so that none of the SARs provided under this Award Agreement or Shares issuable hereunder will be subject to the additional tax imposed under Code Section 409A, and any ambiguities
herein will be interpreted to so comply. 
  

	4.	Exercise of SARs. 

  

	 	(a)	Right to Exercise. The SARs may be exercised only with respect to the portion of the SARs that have vested and only within the term set out in the Notice of Grant, and may be exercised during such term only in
accordance with the Plan and the terms of this Award Agreement. 

  

	 	(b)	Method of Exercise. The SARs are exercisable by delivery of an exercise notice, in the form attached hereto as EXHIBIT B (the “Exercise Notice”), or in a manner and
pursuant to such procedures as the Committee may determine, which will state the election to exercise the SARs, the number of Shares in respect of which the SARs are being exercised (the “Exercised Shares”), and such other
representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Exercise Notice will be completed and executed by Participant and delivered to the Company. The Exercise Notice will be accompanied by
payment of any applicable tax withholding. The SARs will be deemed to be exercised upon receipt by the Company of such fully completed and executed Exercise Notice. 


 

	5.	Company’s Obligation to Pay. The SARs represent the right to receive, upon exercise thereof, an amount of [cash]7 [Shares with a Fair Market Value]8 [Shares with a Fair Market Value or cash]9 equal to the product of: (a) the number of Shares subject to the SARs that are exercised
(Participant may exercise only for whole Shares), and (b) the excess of the Fair Market Value of one Share on the date of exercise over the Exercise Price. 

  

	6.	Form of Payments. The Company will make any payments to Participant under the SARs in the form of [cash, net of applicable withholding taxes in accordance with Section 9]10 [OR] [Shares, with cash paid in lieu of fractional Shares, as determined by the Committee at the time of exercise. Any Shares Participant receives will be free from vesting


  
  

	4 	Include if SARs may be settled only in cash. 


	5 	Include if SARs may be settled only in Shares. 


	6 	Include if SARs may be settled in cash or Shares. 


	7 	Include if SARs may be settled only in cash. 


	8 	Include if SARs may be settled only in Shares. 


	9 	Include if SARs may be settled in cash or Shares. 


	10 	 Include if SARs may be settled only in cash. 



  
 A-2 









	 	
restrictions (but subject to such legends as the Company determines appropriate).]11 [OR] [cash, net of applicable withholding
taxes in accordance with Section 9, or Shares, with cash paid in lieu of fractional Shares, as determined by the Committee at or prior to the time of exercise. Any Shares Participant receives will be free from vesting restrictions (but subject
to such legends as the Company determines appropriate).]12 

  

	7.	Forfeiture upon Termination of Status as a Service Provider. Notwithstanding any contrary provisions of this Award Agreement, subject to the terms of any employment agreement, offer letter, consulting agreement
or similar agreement between Participant, on the one hand, and the Company or any of its Affiliates, on the other hand, that is in effect when Participant’s Continuous Service terminates, immediately upon the termination of Participant’s
Continuous Service for any or no reason, the balance of the SARs that has not vested as of such time, and Participant’s right to acquire any [cash]13 [Shares]14 [cash or Shares]15 hereunder, will be canceled and become automatically null and void in their entirety. 


 

	8.	Death of Participant. Notwithstanding anything to the contrary contained herein or in the Plan, following the execution of this Award Agreement, Participant may expressly designate a death beneficiary (the
“Beneficiary”) to Participant’s interest, if any, in the SARs [and any Shares subject to the SARs]16. Participant may designate the Beneficiary by completing a
designation of death beneficiary agreement substantially in the form attached hereto as EXHIBIT C (the “Designation of Death Beneficiary”) and delivering an executed and notarized copy of the Designation
of Death Beneficiary to the Company. Any distribution or delivery to be made to Participant under this Award Agreement will, if Participant is then deceased, be made to the Beneficiary, or if no Beneficiary has been designated or survives
Participant, the administrator or executor of Participant’s estate. Any such transferee must furnish the Company with (a) written notice of such transferee’s status as transferee, and (b) evidence satisfactory to the Company to
establish the validity of the transfer and compliance with any laws or regulations pertaining to said transfer. 

  

	9.	Tax Obligations. 

  

	 	(a)	Withholding of Taxes. Regardless of any action the Company or Participant’s employer (if other than the Company) (the “Employer”) takes with respect to any or all Withholding Taxes,
if any, that arise upon the grant, vesting or exercise of the SARs [or the holding or subsequent sale of Shares, and the receipt of dividends, if any]17 (“Tax-Related
Items”), Participant acknowledges and agrees that the ultimate liability for all Tax-Related Items legally due by Participant is and remains Participant’s responsibility and may exceed the amount actually 


 
  

	11 	Include if SARs may be settled only in Shares. 


	12 	Include if SARs may be settled in cash or Shares. 


	13 	Include if SARs may be settled only in cash. 


	14 	Include if SARs may be settled only in Shares. 


	15 	Include if SARs may be settled (i) only in Shares or (ii) in cash or Shares. 


	16 	Include if SARs may be settled in Shares. 


	17 	 Include if SARs may be settled in Shares. 



  
 A-3 









	 	
withheld by the Company or the Employer. Participant further acknowledges that each of the Company and the Employer (i) makes no representations or undertakings regarding the treatment of
any Tax-Related Items in connection with any aspect of the SARs including grant, vesting or exercise of the SARs[, the subsequent sale of Shares acquired under the Plan, and the receipt of dividends, if any]18; and (ii) does not commit to and is under no obligation to structure the terms of the SARs or any aspect of the SARs to reduce or eliminate Participant’s liability for Tax-Related Items,
or achieve any particular tax result. Further, if Participant has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, Participant acknowledges that the Company and/or the Employer
(or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. 

  

	 	(b)	Notwithstanding any contrary provisions of this Award Agreement, no [Shares and no]19 payment will be [issued
or]20 made to Participant (or Participant’s estate or Beneficiary) for the SARs unless and until satisfactory arrangements (as determined by the Company) have been made by Participant with
respect to the payment of any Tax-Related Items which the Company determines must be withheld with respect to such [Shares or]21 payment. The Committee, in its sole and absolute discretion and
pursuant to such procedures as it may specify from time to time, may permit Participant to satisfy such Tax-Related Items, in whole or in part (without limitation) by (i) paying cash[, (ii) electing to have the Company withhold otherwise
deliverable Shares having a Fair Market Value equal to the minimum amount required to be withheld,]22 [or][(ii)][(iii)] delivering to the Company already vested and owned Shares having a Fair
Market Value equal to the amount required to be withheld; provided that such Shares have been held for at least the minimum period of time that would allow the Company to avoid adverse accounting consequences[, or (iv) selling a
sufficient number of such Shares otherwise deliverable to Participant through such means as the Company may determine in its sole and absolute discretion (whether through a broker or otherwise) equal to the amount required to be withheld.]23 To the extent determined appropriate by the Company, in its sole and absolute discretion, the Company will have the right (but not the obligation) to satisfy any Tax-Related Items by [(Y) reducing
the number of Shares otherwise deliverable to Participant, or (Z)] withholding from Participant’s wages or other cash compensation payable to Participant by the Company or the Employer. 


[If the obligation for Tax-Related Items is satisfied by withholding Shares, Participant is deemed to have been issued the full number of
Shares purchased for tax purposes, notwithstanding that a number of the Shares is held back solely for the purpose of paying 
  

 

	18 	Include if SARs may be settled in Shares. 


	19 	Include if SARs may be settled in Shares. 


	20 	Include if SARs may be settled in Shares. 


	21 	Include if SARs may be settled in Shares. 


	22 	Include if SARs may be settled in Shares. 


	23 	 Include if SARs may be settled in Shares. 



  
 A-4 









	 	
the Tax-Related Items due as a result of Participant’s participation in the Plan. Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company may be
required to withhold as a result of Participant’s participation in the Plan that cannot be satisfied by one or more of the means previously described in this Section 9.]24 Participant
acknowledges and agrees that the Company may refuse to honor the exercise and refuse to issue or deliver [cash payable upon exercise of the SARs]25 [the Shares or the proceeds of the sale of
Shares]26 [cash payable upon exercise of the SARs or Shares or the proceeds of the sale of Shares]27 if Participant fails to comply with
Participant’s obligations in connection with the Tax-Related Items. 

  

	10.	[Rights as Stockholder. Neither Participant nor any transferee or Beneficiary of Participant shall have any rights as a stockholder of the Company with respect to any Shares subject to the SARs until the date of
issuance of a stock certificate or making of a book entry evidencing the Shares subject to the SARs to Participant or Participant’s transferee or Beneficiary for such Shares in accordance with the Company’s governing instruments and
Applicable Law. Prior to the issuance of Shares pursuant to the SARs, Participant shall not have the right to vote or to receive dividends or any other rights as a stockholder with respect to the Shares subject to the SARs. No adjustment will be
made for a dividend or other right that is determined based on a record date prior to the date the stock certificate is issued or book entry is made, except as otherwise specifically provided for in the Plan.]28 

  

	11.	No Guarantee of Continued Service or Grants. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF THE SHARES SUBJECT TO THE SARS PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY REMAINING IN
CONTINUOUS SERVICE AT THE WILL OF THE COMPANY (OR THE AFFILIATE OF THE COMPANY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED OR RETAINED, BEING GRANTED THE SARS [OR ACQUIRING SHARES HEREUNDER]29. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AWARD AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED
PROMISE THAT PARTICIPANT WILL REMAIN, OR HAVE THE OPPORTUNITY TO REMAIN, IN CONTINUOUS SERVICE, FOR ALL OR ANY PORTION OF THE VESTING PERIOD, FOR ANY OTHER PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT’S RIGHT OR THE
RIGHT OF THE COMPANY (OR THE AFFILIATE OF THE COMPANY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT’S CONTINUOUS SERVICE AT ANY TIME, WITH OR WITHOUT CAUSE. 


 
  

	24 	Include if SARs may be settled in Shares. 


	25 	Include if SARs may be settled only in cash. 


	26 	Include if SARs may be settled only in Shares. 


	27 	Include if SARs may be settled in cash or Shares. 


	28 	Include if SARs may be settled in Shares. 


	29 	Include if SARs may be settled in Shares. 


  
 A-5 









	 	Participant also acknowledges and agrees that: (a) the Plan is established voluntarily by the Company, the Plan is discretionary in nature and the Plan may be modified, amended, suspended or terminated by the
Company at any time; (b) the grant of the SARs is voluntary and occasional and does not create any contractual or other right to receive future grants of SARs, or benefits in lieu of the SARs even if the SARs have been granted repeatedly in the
past; (c) all decisions with respect to future awards of SARs, if any, will be at the sole and absolute discretion of the Company; (d) Participant’s participation in the Plan is voluntary; (e) the SARs [and the Shares subject to
the SARs]30 are extraordinary items that do not constitute regular compensation for services rendered to the Company or the Employer, and are outside the scope of Participant’s employment
agreement, offer letter, consulting agreement or similar agreement, if any; (f) the SARs [and the Shares subject to the SARs]31 are not intended to replace any pension rights or compensation;
(g) the SARs [and the Shares subject to the SARs]32 are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance,
resignation, termination, redundancy, dismissal, or end of service payments, bonuses, long-service awards, pension, retirement or welfare benefits, or similar payments and in no event should be considered as compensation for, or relating in any way
to, past services for the Company or the Employer; and (h) in consideration of the award of the SARs, no claim or entitlement to compensation or damages shall arise from forfeiture of the SARs resulting from termination of employment by the
Company or the Employer (for any reason whatsoever and whether or not in breach of local labor laws), and Participant irrevocably releases the Company and the Employer from any such claim that may arise; if, notwithstanding the foregoing, any such
claim is found by a court of competent jurisdiction to have arisen, Participant shall be deemed irrevocably to have waived Participant’s entitlement to pursue such claim. 


 

	12.	Address for Notices. Any notice to be given to the Company under the terms of this Award Agreement will be addressed to the Company at 11119 North Torrey Pines Road, Suite 50, San Diego, CA 92037, or at such
other address as the Company may hereafter designate in writing. Any notice to be given to Participant under the terms of this Award Agreement will be addressed to Participant at the address that he or she most recently provided to the Company.


  

	13.	Award is Not Transferable[; Shares Subject to Limitations on Transfer]33. Except to the limited extent provided in Section 8, the SARs and the rights and
privileges conferred hereby will not be transferred, assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and will not be subject to sale under execution, attachment or similar process. Upon any attempt to
transfer, assign, pledge, hypothecate or otherwise dispose of the SARs, or any right or privilege conferred hereby, or upon any attempted sale under any execution, attachment or similar process, the SARs and the rights and privileges conferred
hereby immediately will become null and void. 

  
  


	30 	Include if SARs may be settled in Shares. 


	31 	Include if SARs may be settled in Shares. 


	32 	Include if SARs may be settled in Shares. 


	33 	Include if SARs may be settled in Shares. 


  
 A-6 








 [Any Shares issued pursuant to this Award Agreement shall also be subject to any limitations on
transferability imposed under the Company’s Certificate of Incorporation or Bylaws, each as may be amended or restated from time to time, and pursuant to any insider trading, “trading window” or similar policy adopted by the Company
from time to time.]34 
  

	14.	Binding Agreement. Subject to the limitation on the transferability of the SARs, this Award Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and
assigns of the parties hereto. 

  

	15.	[Additional Conditions to Issuance of Stock. If at any time the Company will determine, in its sole and absolute discretion, that the listing, registration or qualification of the Shares upon any national
securities exchange, national market system or automated quotation system or under any state, federal or foreign law, or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the issuance of
Shares to Participant (or Participant’s estate or Beneficiary), such issuance will not occur unless and until such listing, registration, qualification, consent or approval will have been effected or obtained free of any conditions not
acceptable to the Company. Where the Company determines that the delivery of the payment of any Shares will violate federal securities laws or other applicable laws, the Company will defer delivery until the earliest date at which the Company
reasonably anticipates that the delivery of Shares will no longer cause such violation. The Company will make all reasonable efforts to meet the requirements of any such state, federal or foreign law or national securities exchange, national market
system or automated quotation system and to obtain any such consent or approval of any such governmental authority. Assuming such compliance, for income tax purposes the Exercised Shares will be considered transferred to Participant on the date the
SARs are exercised with respect to such Exercised Shares. The Company shall not be obligated to issue any Shares pursuant to the SARs at any time if the issuance of Shares, or the exercise of a SAR by Participant, violates or is not in compliance
with any laws, rules or regulations of the United States, any state or of any other country. 

 Furthermore, the Company
reserves the right to impose other requirements on Participant’s participation in the Plan, on the SARs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with local
law or facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. Furthermore, Participant understands that the laws of the country in
which Participant is resident at the time of grant or vesting of the SARs or the holding or disposition of Shares (including any rules or regulations governing securities, foreign exchange, tax, labor or other matters) may restrict or prevent the
issuance of Shares or may subject Participant to additional procedural or regulatory requirements that Participant is solely responsible for and will have to independently fulfill in relation to the SARs or the Shares. Notwithstanding any provision
herein, the SARs and any Shares shall be subject to any special terms and conditions or disclosures as set forth in any addendum for Participant’s country (which forms a part of this Award Agreement). 

 
  

	34 	Include if SARs may be settled in Shares. 


  
 A-7 








 Notwithstanding any other provision of the Plan or of this Award Agreement, for periods during
which the Shares are not traded or listed on a national securities exchange: (i) the Committee may condition Participant’s receipt of Shares on Participant’s execution of any other stockholders’ or similar agreement imposing
terms generally applicable to other similarly-situated employee-stockholders; and (ii) any Shares issued pursuant to this Award Agreement shall be non-transferable until the first day of the ninth (9th) month following the termination of
Participant’s Continuous Service.]35 
  

	16.	Committee Authority. The Committee will have the power to interpret the Plan and this Award Agreement, and to adopt such rules for the administration, interpretation and application of the Plan as are consistent
therewith, and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any Shares subject to SARs have vested). All actions taken, and all interpretations and determinations made by the Committee in
good faith, will be final, binding and conclusive upon Participant, the Company and all other interested persons. No member of the Committee will be personally liable for any action, determination or interpretation made in good faith with respect to
the Plan or this Award Agreement. 

  

	17.	Electronic Delivery and Language. The Company may, in its sole and absolute discretion, decide to deliver any documents related to SARs awarded under the Plan, or future SARs that may be awarded under the Plan by
electronic means, or request Participant’s consent to participate in the Plan by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through any on-line or
electronic system established and maintained by the Company or another third party designated by the Company. Participant shall not raise the use of electronic delivery as a defense to the formation of a contract. If Participant has received this
Award Agreement, including appendices, or any other document related to the Plan translated into a language other than English, and the meaning of the translated version is different than the English version, the English version will control.


  

	18.	Independent Tax Advice. Participant acknowledges that determining the actual tax consequences to Participant of receiving or disposing of the SARs [and
Shares]36 may be complicated. These tax consequences will depend, in part, on Participant’s specific situation and may also depend on the resolution of currently uncertain tax law and other
variables not within the control of the Company. Participant is aware that Participant should consult a competent and independent tax advisor for a full understanding of the specific tax consequences to Participant of receiving the SARs, exercising
the SARs and receiving [the cash payment]37 [the cash payment or the Shares (and disposing of such Shares)]38. Prior to executing this Award
Agreement, Participant either has consulted with a competent tax advisor independent of the Company to obtain tax advice concerning the receipt of the SARs, and the receipt of the [cash payment]39
[cash 

  
  

	35 	Include if SARs may be settled in Shares. 


	36 	Include if SARs may be settled in Shares. 


	37 	Include if SARs may be settled only in cash. 


	38 	Include if SARs may be settled in Shares. 


	39 	 Include if SARs may be settled only in cash. 



  
 A-8 









	 	
payment or the Shares (and the disposition of such Shares)]40 in light of Participant’s specific situation, or Participant has had the
opportunity to consult with a tax advisor but chose not to do so. 

  

	19.	[Investment Purposes. By executing this Award Agreement, Participant represents and warrants to the Company that any Shares issued to Participant pursuant to the exercise of the SARs will be held for investment
purposes only for Participant’s own account, and not with a view to, for resale in connection with, or with an intent of participating directly or indirectly in, any distribution of such Shares within the meaning of the Securities Act.]41 

  

	20.	[Securities Law Restrictions. Regardless of whether the offering and sale of the SARs [or the Shares issuable under the Plan have been registered under the Securities Act, or have been registered or qualified
under the securities laws of any state, the Company, in its sole and absolute discretion, may impose restrictions upon the sale, pledge or other transfer of such Shares (including, without limitation, the placement of appropriate legends on stock
certificates or the imposition of stop-transfer instructions) if, in the judgment of the Company, such restrictions are necessary or desirable in order to achieve compliance with the Securities Act or the securities laws of any state or any other
law or to enforce the intent of the SARs.]42 

  

	21.	Recoupment. Notwithstanding any other provision herein, the SARs and any [cash]43 [cash, Shares]44 or
other amount or property that may be issued, delivered or paid in respect of the SARs, as well as any consideration that may be received in respect of a sale or other disposition of any such
[cash]45 [cash, Shares]46 or property, shall be subject to recoupment under the Plan, in accordance with any clawback policy that the Company
is required to adopt pursuant to the listing standards of any national securities exchange, national market system or automated quotation system on which the Company’s securities are listed, quoted or traded or as is otherwise required by the
Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, including but not limited to Section 10D of the Exchange Act, or any other Applicable Law, as well as any recoupment or “clawback” policies of the Company that may be
in effect from time to time. 

  

	22.	Participant Acknowledgement of Certain Rights and Restrictions. Participant hereby expressly represents and warrants that Participant has reviewed and understands the provisions of the Plan, including, without
limitation, Sections 14 (Termination, Rescission and Recapture of Awards), 15 (Recoupment of Awards), 23(f) (Data Privacy) [and 23(g) (Participants Outside of the United States)]47 [, 23(g)
(Participants Outside of 

  
  

	40 	Include if SARs may be settled in Shares. 


	41 	Include if SARs may be settled in Shares. 


	42 	Include if SARs may be settled in Shares. 


	43 	Include if SARs may be settled only in cash. 


	44 	Include if SARs may be settled only in Shares or in cash or Shares. 


	45 	Include if SARs may be settled only in cash. 


	46 	Include if SARs may be settled only in Shares or in cash or Shares. 


	47 	 Include if SARs may be settled only in cash. 



  
 A-9 









	 	
the United States), 26 (Repurchase Rights) and 27 (Market Stand-Off) of the Plan]48. Participant acknowledges and agrees that the SARs and the
Shares are subject to the Plan, including without limitation, the foregoing provisions. Participant further acknowledges receipt of and the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the
Securities Act, which includes the Plan prospectus. 

  

	23.	Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Award Agreement, if Participant is a Reporting Person, then the Plan, the SARs and this Award Agreement
shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such
exemptive rule. To the extent permitted by applicable law, this Award Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule. 


 

	24.	Titles; Headings; Sections. The titles and headings of the sections in this Award Agreement are for convenience of reference only and, in the event of any conflict, the text of this Award Agreement, rather than
such titles or headings, shall control. A reference to a “Section” in this Award Agreement shall mean a Section of this Award Agreement. 

  

	25.	Severability. Whenever possible, each provision of this Award Agreement shall be interpreted in such manner as to be effective and valid under applicable law. In the event that any one or more of the provisions
of this Award Agreement shall be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not be affected thereby. If, in the opinion of any court of
competent jurisdiction, such covenants are not reasonable in any respect, such court shall have the right, power and authority to excise or modify such provision or provisions of these covenants that are, in the court’s opinion, not reasonable,
and to enforce the remainder of these covenants as so amended. Regardless of whether a court replaces any such provisions, the balance of this Award Agreement shall be enforceable in accordance with its terms and this entire Award Agreement shall
remain enforceable in any other jurisdiction. 

  

	26.	Modifications to the Award Agreement. This Award Agreement, together with the Plan and the exhibits attached to this Award Agreement, constitutes the entire understanding of the parties on the subjects covered
hereby and thereby. Participant expressly warrants that Participant is not accepting this Award Agreement in reliance on any promises, representations or inducements other than those contained herein. Modifications to this Award Agreement or the
Plan can be made only in an express written contract executed by a duly authorized officer of the Company (other than Participant). Notwithstanding anything to the contrary in the Plan or this Award Agreement, the Company reserves the right to
revise this Award Agreement as it deems necessary or advisable, in its sole and absolute discretion and without the consent of Participant, to comply with Code Section 409A or to otherwise avoid imposition of any additional tax or income
recognition under Code Section 409A in connection with the SARs. 

  

 

	48 	Include SARs may be settled in Shares. 


  
 A-10 









	27.	Imposition of Other Requirements. The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the SARs [and on any Shares acquired under the SARs]49, to the extent the Company determines it is necessary or advisable in order to comply with Applicable Law or facilitate the administration of the Plan, and to require Participant to sign any
additional agreements or undertakings that may be necessary or advisable to accomplish the foregoing. 

  

	28.	Data Privacy. Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s personal data as described in this Award
Agreement by and among, as applicable, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan. Participant understands that the Company and its Affiliates may
hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, date of birth, social insurance or security number or other identification number, salary, nationality,
job title(s), any shares of stock or directorships held in the Company or any Affiliate, details of all SARs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor, for
the exclusive purpose of implementing, administering and managing the Plan (“Personal Data”). Participant understands that Personal Data may be transferred to any third parties assisting in the implementation, administration and management
of the Plan, that these recipients may be located in the United States, Participant’s country (if different than the United States), or elsewhere, and that the recipient’s country may have different data privacy laws and protections than
Participant’s country. 

 For Participants located in the European Union, the following
paragraph applies: Participant understands that Participant may request a list with the names and addresses of any potential recipients of Personal Data by contacting Participant’s local human resources representative. Participant authorizes
the recipients to receive, possess, use, retain and transfer Personal Data, in electronic or other form, for the purposes of implementing, administering and managing Participant’s participation in the Plan, [including any requisite transfer of
such Personal Data as may be required to a broker or other third party with whom Participant may elect to deposit any Shares received upon exercise of the SARs]50. Participant understands that
Personal Data will be held only as long as is necessary to implement, administer and manage Participant’s participation in the Plan. Participant understands that Participant may, at any time, view Personal Data, request additional information
about the storage and processing of Personal Data, require any necessary amendments to Personal Data or refuse or withdraw the consents herein, without cost, by contacting in writing Participant’s local human resources representative.
Participant understands that refusal or withdrawal of consent may affect Participant’s ability to participate in the Plan or to realize benefits 
  

 

	49 	Include if SARs may be settled in Shares. 


	50 	 Include if the SARs may be settled in Shares. 



  
 A-11 









	 	
from the Plan. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that Participant may contact Participant’s
local human resources representative. 

  

	29.	Foreign Exchange Fluctuations and Restrictions. Participant understands and agrees that the future value of the underlying Shares is unknown and cannot be predicted with certainty[; further, if Participant
exercises the SARs and obtains Shares, the value of the Shares acquired upon exercise may increase or decrease in value, even below the Exercise Price]51. Participant also understands that neither
the Company, nor any Affiliate is responsible for any foreign exchange fluctuation between local currency and the United States Dollar or the selection by the Company or any Affiliate, in its sole and absolute discretion, of an applicable foreign
currency exchange rate that may affect the value of the SARs [or Shares received]52 (or the calculation of income or Tax-Related Items thereunder). [Participant understands and agrees that any
cross border remittance made to transfer proceeds received upon the sale of any Shares must be made through a locally authorized financial institution or registered foreign exchange agency and may require Participant to provide such entity with
certain information regarding the transaction.]53 

  

	30.	The Plan. By accepting the SARs, Participant expressly warrants that Participant has received SARs under the Plan, and has received, read, acknowledged and understood the Plan. 


 

	31.	Governing Law; Venue. This Award Agreement shall be governed by and construed in accordance with the laws of the State of Delaware as applied to agreements entered into among Delaware residents to be performed
entirely within Delaware, without regard to principles of conflicts of law. For purposes of litigating any dispute that arises under this award of SARs or this Award Agreement, Participant hereby submits to and consents to the exclusive jurisdiction
of the State of California, and agrees that such dispute will be handled in the courts of the County of San Diego, State of California, or the federal courts for the United States for the Southern District of California, and no other courts.


  

	32.	[Power of Attorney; Stock Certificates. In order to secure Participant’s obligations in respect of any exercise of any repurchase rights under the Plan and this Award Agreement, Participant hereby
constitutes and appoints the Board (and any member or designee of the Board), with full power of substitution, as Participant’s true and lawful agent and attorney-in-fact, with full power and authority in such holder’s name, place and
stead, to execute, swear to, acknowledge, deliver, file and record all instruments and other documents and do such other acts which the Board deems appropriate or necessary to effect or evidence any repurchase of Shares pursuant to this Award
Agreement and the Plan, and such power of attorney may be exercised at any time and from time to time. The foregoing power of attorney is irrevocable and coupled with an interest, and shall survive Participant’s death, disability, incapacity,
dissolution, bankruptcy, insolvency or 

  
  

	51 	Include if SARs may be settled in Shares. 


	52 	Include if SARs may be settled in Shares. 


	53 	 Include if the SARs may be settled in Shares. 



  
 A-12 









	 	
termination and the transfer of all or any portion of the Shares and shall extend to Participant’s heirs, successors, assigns, transferees and personal representatives. In addition, until
release upon consummation of an Initial Public Offering, all certificates evidencing the Shares shall be held by the Company for Participant’s benefit and the benefit of the Company’s other stockholders. The purpose of the Company’s
retention of such certificates is solely to facilitate any repurchase of Shares pursuant to this Award Agreement and the Plan and does not constitute a pledge of, or the granting of a security interest in, the underlying Shares.]54 

 [Remainder of Page Intentionally Left Blank] 

 
  

	54 	Include if the SARs may be settled in Shares. 


  
 A-13 








 EXHIBIT B 

EXERCISE NOTICE 

Viking Therapeutics, Inc. 
 11119 North Torrey Pines Road, Suite
50 
 San Diego, CA 92037 
  

	1.	Exercise of SARs. Effective as of today,             , 20    , the undersigned (“Purchaser”) hereby
elects to purchase                  shares (the “Shares”) of the Common Stock of Viking Therapeutics, Inc. (the
“Company”) under and pursuant to the Viking Therapeutics, Inc. 2014 Equity Incentive Plan (as amended or restated from time to time, the “Plan”) and the Stock Appreciation Rights Award Agreement dated
            , 20     (the “Award Agreement”).

  

	2.	Delivery of Payment. Purchaser herewith delivers to the Company any required tax withholding to be paid in connection with the exercise of the SARS. 


 

	3.	Representations of Purchaser. Purchaser acknowledges that Purchaser has received, read and understood the Plan and the Award Agreement and agrees to abide by and be bound by their terms and conditions.


  

	4.	Rights as Stockholder. Until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the Shares, no right to vote or receive
dividends or any other rights as a stockholder will exist with respect to the Shares subject to the SARs, notwithstanding the exercise of the SARs. The Shares so acquired will be issued to Purchaser as soon as practicable after exercise of the
SARs. No adjustment will be made for a dividend or other right for which the record date is prior to the date of issuance, except as provided in Section 13(a) of the Plan. 


 

	5.	Tax Consultation. Purchaser understands that Purchaser may suffer adverse tax consequences as a result of Purchaser’s purchase or disposition of the Shares. Purchaser represents that Purchaser has
consulted with any tax consultants Purchaser deems advisable in connection with the purchase or disposition of the Shares and that Purchaser is not relying on the Company or any of its Affiliates for any tax advice. 


 

	6.	Entire Agreement; Governing Law. The Plan and Award Agreement are incorporated herein by reference. This Exercise Notice, the Plan and the Award Agreement constitute the entire agreement of the parties
with respect to the subject matter hereof and thereof and supersede in their entirety all prior undertakings and agreements of the Company and Purchaser with respect to the subject matter hereof and thereof, and may not be modified adversely to the
Purchaser’s interest except by means of a writing signed by the Company and Purchaser. This Exercise Notice shall be governed by and construed in accordance with the laws of the State of Delaware as applied to agreements entered into among
Delaware residents to be performed entirely within Delaware, without regard to principles of conflicts of law. 


  
 B-1 









			
	Submitted by:	 	Accepted by:
		
	PURCHASER:	 	VIKING THERAPEUTICS, INC.
		
	  
	 	  

	Signature	 	By
		
	  
	 	  

	Print Name	 	Name
		
	Address:	 	  

		 	Title
		
		 	  

		 	Date Received


  
 B-2 








 EXHIBIT C 

DESIGNATION OF DEATH BENEFICIARY 

In connection with the Award(s) designated below that I have received pursuant to the Viking Therapeutics, Inc. 2014 Equity Incentive Plan (as
amended or restated from time to time, the “Plan”), I hereby designate the person specified below as the beneficiary upon my death of my interest in such Awards. This designation shall remain in effect until revoked in
writing by me. 
  

					
	Name of Beneficiary:	 	  
	 	
			
	Address:	 	  
	 	
			
		 	  
	 	
			
		 	  
	 	
			
	Social Security No.:	 	  
	 	

 This beneficiary designation relates to any and all of my rights under the following Award or Awards: 

 

	 	 ̈	any Award that I have received or ever receive under the Plan. 

  

	 	 ̈	the              Award that I received pursuant to an award agreement with a Grant Date of
            ,              between myself and Viking Therapeutics, Inc. 


I understand that this designation operates to entitle the above named beneficiary, in the event of my death, to any and all of my rights
under the Award(s) designated above from the date this executed and notarized form is delivered to the Company until such date as this designation is revoked in writing by me, including by delivery to the Company of a written, executed and notarized
designation of beneficiary executed by me on a later date. 
  

			
	Date:	 	  

		
	By:	 	  

		 	Name of Participant


 Sworn to before me this 

             day of             ,
20     

                          
                                   

Notary Public 
 County of
                                     

State of
                                        


  
 C-1